These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 27470350

  • 61. Allolobophora caliginosa coelomic fluid and extract alleviate glucocorticoid-induced osteoporosis in mice by suppressing oxidative stress and regulating osteoblastic/osteoclastic-related markers.
    Abdelfattah MA, Mohamed AS, Ibrahim SA, Fahmy SR.
    Sci Rep; 2023 Feb 06; 13(1):2090. PubMed ID: 36746995
    [Abstract] [Full Text] [Related]

  • 62. Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment.
    Shen G, Ren H, Qiu T, Liang D, Wei Q, Tang J, Zhang Z, Yao Z, Zhao W, Jiang X.
    Biochem Biophys Res Commun; 2016 Sep 02; 477(4):1059-1064. PubMed ID: 27402272
    [Abstract] [Full Text] [Related]

  • 63. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E.
    Curr Opin Rheumatol; 2003 Jul 02; 15(4):454-7. PubMed ID: 12819474
    [Abstract] [Full Text] [Related]

  • 64. Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula.
    Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K, Zheng H.
    J Ethnopharmacol; 2008 Jul 23; 118(2):271-9. PubMed ID: 18501540
    [Abstract] [Full Text] [Related]

  • 65. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone.
    Wong KC, Pang WY, Wang XL, Mok SK, Lai WP, Chow HK, Leung PC, Yao XS, Wong MS.
    Br J Nutr; 2013 Aug 28; 110(3):475-85. PubMed ID: 23302510
    [Abstract] [Full Text] [Related]

  • 66. Mechanisms of glucocorticoid action in bone.
    Canalis E, Delany AM.
    Ann N Y Acad Sci; 2002 Jun 28; 966():73-81. PubMed ID: 12114261
    [Abstract] [Full Text] [Related]

  • 67. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N, Suzuki A.
    Clin Calcium; 2013 Sep 28; 23(9):1337-44. PubMed ID: 23999371
    [Abstract] [Full Text] [Related]

  • 68. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A.
    Trends Endocrinol Metab; 2006 Sep 28; 17(4):144-9. PubMed ID: 16678739
    [Abstract] [Full Text] [Related]

  • 69. Multitargeted combination effects of a triherbal formulation containing ELP against osteoporosis: in vitro evidence.
    Ko CH, Lau KM, Chau L, Cheung DW, Siu WS, Wong HL, Shum WT, Gao S, Fung KP, Leung PC, Poon SK, Lau CB.
    J Pharm Pharmacol; 2016 Jun 28; 68(6):826-33. PubMed ID: 27019348
    [Abstract] [Full Text] [Related]

  • 70. Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.
    Shuai B, Yang YP, Shen L, Zhu R, Xu XJ, Ma C, Lv L, Zhao J, Rong JH.
    Osteoporos Int; 2015 Mar 28; 26(3):1063-71. PubMed ID: 25516362
    [Abstract] [Full Text] [Related]

  • 71. Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian Decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7.
    Zhu Z, Xue LM, Han T, Jiao L, Qin LP, Li YS, Zheng HC, Zhang QY.
    Molecules; 2010 Jul 05; 15(7):4695-710. PubMed ID: 20657386
    [Abstract] [Full Text] [Related]

  • 72. Effects of glucocorticoid-induced osteoporosis on bone tissue of rats with experimental periodontitis.
    Sousa LH, Moura EV, Queiroz AL, Val D, Chaves H, Lisboa M, Furlaneto F, Brito GA, Goes P.
    Arch Oral Biol; 2017 May 05; 77():55-61. PubMed ID: 28178585
    [Abstract] [Full Text] [Related]

  • 73. Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways.
    Jiang Y, Lu Y, Jiang X, Hu J, Li R, Liu Y, Zhu G, Rong X.
    Biomed Pharmacother; 2020 May 05; 125():109979. PubMed ID: 32044718
    [Abstract] [Full Text] [Related]

  • 74. Protective Role of β-Sitosterol in Glucocorticoid-Induced Osteoporosis in Rats Via the RANKL/OPG Pathway.
    Wang T, Li S, Yi C, Wang X, Han X.
    Altern Ther Health Med; 2022 Oct 05; 28(7):18-25. PubMed ID: 35648689
    [Abstract] [Full Text] [Related]

  • 75. Transcriptome analysis reveals functional roles of nacreous protein N16 in prednisolone-induced osteoporotic zebrafish.
    Lin JB, Wu H, Liu YL, Shaw PC, Li PB.
    Int J Biol Macromol; 2019 Feb 01; 122():1071-1079. PubMed ID: 30219513
    [Abstract] [Full Text] [Related]

  • 76. Screening for natural medicines effective for the treatment of osteoporosis.
    Suzuki R, Fukami S, Tomomura M, Tomomura A, Shirataki Y.
    J Nat Med; 2019 Jan 01; 73(1):331-337. PubMed ID: 30392168
    [Abstract] [Full Text] [Related]

  • 77. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
    Jin X, Zhu L, Li X, Jia J, Zhang Y, Sun X, Ma J, Liu Z, Ma X.
    Mol Med Rep; 2017 Feb 01; 15(2):890-898. PubMed ID: 28000877
    [Abstract] [Full Text] [Related]

  • 78. An evaluation of the effect of pulsed wave low-level laser therapy on the biomechanical properties of the vertebral body in two experimental osteoporosis rat models.
    Bayat M, Fridoni M, Nejati H, Mostafavinia A, Salimi M, Ghatrehsamani M, Abdollahifar MA, Najar A, Bayat S, Rezaei F.
    Lasers Med Sci; 2016 Feb 01; 31(2):305-14. PubMed ID: 26719056
    [Abstract] [Full Text] [Related]

  • 79. [Assessment of the treatment of glucocorticoid-induced osteoporosis].
    Asano S, Suzuki A.
    Clin Calcium; 2013 Mar 01; 23(3):401-8. PubMed ID: 23445894
    [Abstract] [Full Text] [Related]

  • 80. Possible mechanisms of prednisolone-induced osteoporosis in zebrafish larva.
    He H, Wang C, Tang Q, Yang F, Xu Y.
    Biomed Pharmacother; 2018 May 01; 101():981-987. PubMed ID: 29635908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.